[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342872-105":59,"doc-detail-342872-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-importance-of-combined-hpv-and-cintec-plus-genotyping-testing-for-p16-in-women-with-cervical-squamous-cell-carcinoma","The importance of combined HPV and CINtec® PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma","","Immunohistochemistry (IHC) for p16INK4A (p16) functions as a surrogate marker for high-risk, potentially transformative HPV infection in cervical precursor and malignant lesions. This study evaluated how persistent HPV infection alters cervical cells by comparing p16 IHC with HPV genotyping in women presenting with genital complaints. Among 41 patients, 53.7% were HPV positive and 56.1% were p16 positive, with very high agreement (weighted kappa 0.951). CINtec® PLUS triage for p16 showed high PPV and NPV for HPV (95.7% and 100%).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-importance-of-combined-hpv-and-cintec-plus-genotyping-testing-for-p16-in-women-with-cervical-squamous-cell-carcinoma/342872/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-importance-of-combined-hpv-and-cintec-plus-genotyping-testing-for-p16-in-women-with-cervical-squamous-cell-carcinoma/342872.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is p16INK4A (p16) used in cervical lesion testing?","Question",{"text":112,"@type":113},"p16 IHC is described as a reliable surrogate test indicating the presence of high-risk, potentially transformative HPV infection in cervical precursor and malignant lesions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study compare HPV status with p16 status?",{"text":117,"@type":113},"Cytology, p16 IHC, and HPV type determination were performed, then the agreement between HPV positivity and p16 positivity was assessed statistically.",{"name":119,"@type":110,"acceptedAnswer":120},"What diagnostic performance did CINtec® PLUS triage for p16 show for HPV?",{"text":121,"@type":113},"CINtec® PLUS triage for p16 showed high positive predictive value (PPV) and negative predictive value (NPV) for HPV, reported as 95.7% and 100%, respectively.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342872,1790187307,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","ORIGINAL PAPER  \nR J M E  \nRomanian Journal of Morphology & Embryology  \n[http://www.rjme.ro/](http://www.rjme.ro/)  \nThe importance of combined HPV and CINtec® PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma  \nTOADER SEPTIMIU VOIDĂZAN1), MIHAELA ALEXANDRA BUDIANU1), OVIDIU SIMION COTOI2), SABIN GLIGORE TURDEAN2)  \n1) Department of Epidemiology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology ofTârgu Mureş, Romania  \n2) Department of Pathology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, Romania  \nAbstract  \nIntroduction: Immunohistochemistry (IHC) for p16INK4A (p16) is a reliable surrogate test for the presence of a high-risk, potentially transformative human papillomavirus (HPV) infection in precursor and malignant lesions of the cervix. The purpose of this study was to evaluate changes in cervical cells caused by persistent HPV infection, by IHC (p16 protein) by comparison with HPV genotyping. Patients, Materials and Methods: The study included female patients aged between 26 and 57 years who presented to a public hospital, with complaints related to the genital area, namely vaginal bleeding and dyspareunia. After selecting the patients, samples were subjected to cytological testing and IHC for p16 and for the determination of HPV types. Results: The relationship between HPV status and p16 status was statistically significant (p=0 .0001), of the 41 patients, 53 .7% were HPV positive, respectively 56 . 1% were p16 positive, the agreement relationship between the two indicators was very high (weighted kappa: 0 .951) . The clinical performance of CINtec® PLUS triage for p16 shows a high positive predictive value (PPV) and a high negative predictive value (NPV) of 95 .7% and 100%, respectively, as regards HPV. Conclusions: The p16 marker (CINtec® PLUS) can be used as a prognostic biomarker and provides clinical usefulness through increased sensitivity (Se) and specificity (Sp) in the triage of women at risk of developing precancerous lesions, compared to cytology that is based on morphology, but has a rather low Se and high Sp, while HPV testing is very sensitive but slightly more specific.  \nKeywords: cervical cancer, screening, human papillomavirus, p16 (CINtec® PLUS) .  \n􀀕 Introduction  \nCervical carcinoma (CC) is the fourth most common cancer in women, with an incidence of 604 127 new cases and 341 831 deaths worldwide in 2020 [1], with 80–90% of CCs being squamous cell carcinomas (SCCs) [2] .  \nThe disease is largely preventable, and, in high-income countries, the incidence and mortality because of CC have decreased considerably in the last 30 years since the introduction of screening programs and, in recent years, vaccination against human papillomavirus (HPV) . About 85% of CCs occur in low-and middle-income countries without organized HPV screening and vaccination programs [3, 4] .  \nHigh-risk (HR)-HPV genotypes cause the vast majority (90–95%) ofSCCs [2]. Fifteen types of HPVs are classified by the World Health Organization (WHO) as oncogenic:  \n16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and  \n82, but two types (16 and 18) are responsible for 70% of the total SCCs. Other HPV types have been rarely but consistently identified as single HPV infections in about 3% of CCs and are classified as likely/possibly carcinogenic:  \n26, 53, 66, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108 . Very rarely, low-risk HPV genotypes like 6 and 11 have been identified as the sole cause of cervical SCC [5–7] .  \nProgression of high-grade lesions to SCC requires the accumulation of additional epigenetic and genetic changes, still not completely understood, a process that can last for 20–30 years. HPV-associated cervical SCC develops from a high-grade squamous intraepithelial lesion (HSIL) asa result of high levels of expression of E6 and E7 viral oncogenes in dividing epithelia","cbCaiooKaePOuNYU","https://ap.wps.com/l/cbCaiooKaePOuNYU","pdf",1695087,"English","# Abstract\n# Introduction\n## Epidemiology and risk factors\n## HPV oncogenic types and progression\n## Screening and biomarker rationale\n# Aim","[{\"question\":\"Why is p16INK4A (p16) used in cervical lesion testing?\",\"answer\":\"p16 IHC is described as a reliable surrogate test indicating the presence of high-risk, potentially transformative HPV infection in cervical precursor and malignant lesions.\"},{\"question\":\"How did the study compare HPV status with p16 status?\",\"answer\":\"Cytology, p16 IHC, and HPV type determination were performed, then the agreement between HPV positivity and p16 positivity was assessed statistically.\"},{\"question\":\"What diagnostic performance did CINtec® PLUS triage for p16 show for HPV?\",\"answer\":\"CINtec® PLUS triage for p16 showed high positive predictive value (PPV) and negative predictive value (NPV) for HPV, reported as 95.7% and 100%, respectively.\"}]","The importance of combined HPV and CINtec® PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma | PDF",1790048521,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49bb6fdcd0ca2c31406ee83b129e6853.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/056b3d422516e97f3747381b4eccf2bd.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ebec6f67262e49926601c9d60296317.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4168b2dd85c999d114d4a3ce7c0adcd6.webp",980,1385]